Graft- and transplantation-related characteristics
| . | sUCBT . | Haplo-Cord . | P . |
|---|---|---|---|
| HLA compatibility, no. (%)* | .1 | ||
| 6 of 6 | 8 (6) | 5 (8) | |
| 5 of 6 | 38 (28) | 19 (29) | |
| 4 of 6 | 89 (66) | 42 (63) | |
| ABO blood group mismatch, no. (%) | .2 | ||
| Major | 31 (23) | 12 (19) | |
| Minor | 43 (32) | 15 (23) | |
| None | 60 (45) | 37 (58) | |
| No. of nucleated cells infused × 107/kg, median (range) | 2.5 (1.2-5.8) | 2.4 (1.2-6) | .2 |
| CB units according to nucleated cells × 107/kg, no. (%) | .2 | ||
| <1.5 | 8 (6) | 7 (10) | |
| 1.6-2.5 | 59 (47) | 31 (43) | |
| 2.6-3.5 | 35 (28) | 27 (37) | |
| >3.5 | 24 (19) | 7 (10) | |
| No. of CD34+ cells infused × 105/kg, median (range) | 1.3 (0.1-10) | 1.5 (0.4-4) | 1 |
| . | sUCBT . | Haplo-Cord . | P . |
|---|---|---|---|
| HLA compatibility, no. (%)* | .1 | ||
| 6 of 6 | 8 (6) | 5 (8) | |
| 5 of 6 | 38 (28) | 19 (29) | |
| 4 of 6 | 89 (66) | 42 (63) | |
| ABO blood group mismatch, no. (%) | .2 | ||
| Major | 31 (23) | 12 (19) | |
| Minor | 43 (32) | 15 (23) | |
| None | 60 (45) | 37 (58) | |
| No. of nucleated cells infused × 107/kg, median (range) | 2.5 (1.2-5.8) | 2.4 (1.2-6) | .2 |
| CB units according to nucleated cells × 107/kg, no. (%) | .2 | ||
| <1.5 | 8 (6) | 7 (10) | |
| 1.6-2.5 | 59 (47) | 31 (43) | |
| 2.6-3.5 | 35 (28) | 27 (37) | |
| >3.5 | 24 (19) | 7 (10) | |
| No. of CD34+ cells infused × 105/kg, median (range) | 1.3 (0.1-10) | 1.5 (0.4-4) | 1 |
Percentages may not sum to 100 because of rounding.
HLA class I antigens (A and B) considering the antigen level and class II antigen (DRB1) considering allele level resolution DNA typing.